Business
InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs
InMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affair...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nInMed Pharmaceuticals, Inc. Appoints Senior Vice President, Clinical and Regulatory Affairs\nCanada NewsWire\nVANCOUVER, Oct. 31, 2016\n\n\n\n\n\n\nCSE: IN OTCQB: IMLFF\n\n\n\nVANCOUVER, Oct. 31, 2016 /CNW/ - InMed Pharmaceuticals, Inc. (\"InMed\") (CSE: IN; OTCQB: IMLFF), today announced the appointment of Alexandra D.J. Mancini, M.Sc., as Senior Vice President, Clinical and Regulatory Affairs.\n\n\"Ms. Mancini has over 30 years' global biopharmaceutical R&D experience with a particular emphasis on clinical development and regulatory affairs. She has established an outstanding track record, having supported the advancement of products through the regulatory process in the United States, Canada and Europe,\" says Eric A. Adams, President and CEO of InMed. \"As part of our Senior Management team, Ms. Mancini's vast knowledge and network in the field of drug development will play a significant role in advancing InMed's products through the clinical and regulatory process.\"\n\nIn addition to her activities via her private consulting company True North Synergy, Ms. Mancini has been an executive with several biotech companies, overseeing a wide range of drug development activities.  As Sr. VP of Clinical & Regulatory Affairs at Sirius Genomics, her role included identifying and managing external resources for medical expertise in sepsis; clinical data management; and statistical theory, programming and analyses.  While at INEX Pharmaceuticals as Sr. VP of Clinical & Regulatory Affairs, Ms. Mancini oversaw Clinical Research, Medical Affairs, Clinical Data Management, Medical Writing, Regulatory Affairs, and Quality Assurance for oncology.  She served as VP of Regulatory Affairs at QLT Inc. for oncology and ocular diseases, playing a significant role in the development of VISUDYNE® from the preclinical stage through to its approval as the first drug for age-related macular degeneration. While at QLT,...